申请人:Merck Sharp & Dohme Corp.
公开号:US08124628B2
公开(公告)日:2012-02-28
The instant invention provides compounds of Formula II which are 5-lipoxygenase activating protein inhibitors.
Compounds of Formula II are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.
本发明提供了公式II的化合物,它们是5-脂氧合酶激活蛋白抑制剂。公式II的化合物可用作抗动脉粥样硬化、抗哮喘、抗过敏、抗炎和细胞保护剂。